Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands		Total		Common Stock		Additional Paid-in Capital	Accumulated Deficit	Noncontrolling Interest
Beginning Balance at Dec. 31, 2019	[1]	$ 78,711		$ 147		$ 277,787	$ (356,645)	$ 0
Beginning Balance, Shares at Dec. 31, 2019	[1]			147,157,801
Net income (loss) attributable to Alignment Healthcare, Inc.		(1,707)		$ 0		0	(1,707)	0
Issuance of common stock, net of issuance costs		131,629		$ 17		131,612	0	0
Issuance of common stock, net of issuance costs, Shares				16,905,986
Equity-based compensation		676		$ 0		676	0	0
Equity repurchase		(1,023)		0		(1,023)	0	0
Ending Balance at Jun. 30, 2020	[2]	50,864		$ 164		409,052	(358,352)	0
Ending Balance, Shares at Jun. 30, 2020	[2]			164,063,787
Beginning Balance at Mar. 31, 2020	[2]	42,327		$ 164		408,880	(366,717)	0
Beginning Balance, Shares at Mar. 31, 2020	[2]			164,063,787
Net income (loss) attributable to Alignment Healthcare, Inc.		8,365		$ 0		0	8,365	0
Common stock issuance costs		329		0		329	0	0
Equity-based compensation		350		0		350	0	0
Equity repurchase		(507)		0		(507)	0	0
Ending Balance at Jun. 30, 2020	[2]	50,864		$ 164		409,052	(358,352)	0
Ending Balance, Shares at Jun. 30, 2020	[2]			164,063,787
Beginning Balance at Dec. 31, 2020	[1]	$ 30,611	[3]	$ 164		410,018	(379,571)	0
Beginning Balance, Shares at Dec. 31, 2020		164,063,787		164,063,787	[1]
Net income (loss) attributable to Alignment Healthcare, Inc.		$ (101,636)		$ 0		0	(101,636)	0
Net loss attributable to noncontrolling interest		0
Noncontrolling interest attributable to subsidiary		15		0		0	0	15
Issuance of common stock, net of issuance costs		361,589		$ 22		361,567	0	0
Issuance of common stock, net of issuance costs, Shares				21,700,000
Issuance of common stock to third-party business partners		6,480		$ 1		6,479	0	0
Issuance of common stock to third-party business partners, Shares				573,782
Issuance of common stock to stock appreication rights holders		11,510		$ 1		11,509	0	0
Issuance of common stock to stock appreication rights holders, Shares				936,213
Equity-based compensation		33,285		$ 0		33,285	0	0
Equity repurchase		(1,474)		0		(1,474)	0	0
Ending Balance at Jun. 30, 2021		$ 340,380		$ 188		821,384	(481,207)	15
Ending Balance, Shares at Jun. 30, 2021		187,273,782		187,273,782
Beginning Balance at Mar. 31, 2021		$ 354,252		$ 188		790,509	(436,445)	0
Beginning Balance, Shares at Mar. 31, 2021				187,273,782
Net income (loss) attributable to Alignment Healthcare, Inc.		(44,762)		$ 0		0	(44,762)	0
Net loss attributable to noncontrolling interest		0
Noncontrolling interest attributable to subsidiary		15		0		0	0	15
Common stock issuance costs		(12)		0		(12)	0	0
Equity-based compensation		30,887		0		30,887	0	0
Ending Balance at Jun. 30, 2021		$ 340,380		$ 188		$ 821,384	$ (481,207)	$ 15
Ending Balance, Shares at Jun. 30, 2021		187,273,782		187,273,782

[1] The consolidated balances as of December 31, 2020 and 2019 were derived from the audited consolidated financial statements as of that date and were retroactively adjusted, including shares and per share amounts, as a result of the Reorganization. See Note 1 to the condensed consolidated financial statements for additional details.

[2] The consolidated balances as of March 31, 2020 and June 30, 2020 were derived from the audited consolidated financial statements as of that date and were retroactively adjusted, including shares and per share amounts, as a result of the Reorganization. See Note 1 to the condensed consolidated financial statements for additional details.

[3] The condensed consolidated balance sheet as of December 31, 2020 was derived from the audited consolidated financial statements as of that date and was retroactively adjusted, including shares and per share amounts, as a result of the Reorganization. See Note 1 to the condensed consolidated financial statements for additional details.